Surgery Partners (NASDAQ:SGRY) Sees Unusually-High Trading Volume - Still a Buy?

Shares of Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) saw an uptick in trading volume on Monday . 737,102 shares were traded during mid-day trading, an increase of 7% from the previous session's volume of 685,897 shares.The stock last traded at $20.53 and had previously closed at $20.65.

Analyst Ratings Changes

SGRY has been the topic of a number of research reports. UBS Group initiated coverage on shares of Surgery Partners in a research report on Monday, October 14th. They set a "buy" rating and a $38.00 target price on the stock. KeyCorp began coverage on shares of Surgery Partners in a research note on Friday, October 11th. They issued a "sector weight" rating for the company. JPMorgan Chase & Co. lowered their price objective on shares of Surgery Partners from $38.00 to $28.00 and set a "neutral" rating for the company in a research report on Tuesday, December 3rd. Bank of America started coverage on shares of Surgery Partners in a research report on Monday, December 16th. They set a "buy" rating and a $30.00 price objective for the company. Finally, Royal Bank of Canada decreased their target price on shares of Surgery Partners from $49.00 to $35.00 and set an "outperform" rating for the company in a research report on Wednesday, November 20th. One analyst has rated the stock with a sell rating, three have given a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $36.56.

Surgery Partners Stock Performance

The stock's fifty day moving average price is $23.00 and its two-hundred day moving average price is $27.36. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. The company has a market cap of $2.69 billion, a P/E ratio of -44.08, a P/E/G ratio of 17.40 and a beta of 2.58.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its quarterly earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.06). Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The business had revenue of $770.40 million during the quarter, compared to analyst estimates of $768.99 million. During the same quarter last year, the company posted $0.15 earnings per share. The company's revenue was up 14.3% compared to the same quarter last year. As a group, equities analysts predict that Surgery Partners, Inc. will post 0.71 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Quarry LP lifted its position in shares of Surgery Partners by 133.1% during the second quarter. Quarry LP now owns 3,082 shares of the company's stock valued at $73,000 after purchasing an additional 1,760 shares in the last quarter. KBC Group NV lifted its position in shares of Surgery Partners by 31.8% during the third quarter. KBC Group NV now owns 2,385 shares of the company's stock valued at $77,000 after purchasing an additional 576 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. increased its holdings in Surgery Partners by 747.6% during the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company's stock worth $124,000 after buying an additional 3,379 shares during the last quarter. Creative Planning purchased a new stake in Surgery Partners during the third quarter worth about $258,000. Finally, Versor Investments LP purchased a new stake in Surgery Partners during the third quarter worth about $271,000.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.